Clinical Trials Browser

Phase 2 × Completed × Choriocarcinoma × Clear all

NCT02396511 2019-06-11

TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma

Phase 2 Completed

2 enrolled 10 charts

Choriocarcinoma

NCT00190918 2007-08-09

A Trial for Patients With Gestational Trophoblastic Disease

Phase 2 Completed

Choriocarcinoma, Hydatidiform Mole, Trophoblastic Neoplasms, Uterine Neoplasms